Last updated on October 2017

An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia


Brief description of study

The purpose of this study is to determine the safety and effectiveness of ulocuplumab in combination with low dose cytarabine in the treatment of Newly Diagnosed Acute Myeloid Leukemia (AML).

Clinical Study Identifier: NCT02305563

Contact Investigators or Research Sites near you

Start Over

Site 0029

Local Institution
New Taipei City, Taiwan
0.74miles
  Connect »